Monitoring of Patients With Inflammatory Bowel Diseases: the Experience of the Reference Center of the Emilia-Romagna
Observational · No treatment assigned · 1 site · IRCCS Azienda Ospedaliero-Universitaria di Bologna
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: IBD - Inflammatory Bowel Disease. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 14 and older
- Any sex
Some of the main requirements, copied from the record:
- Signed informed consent
- Age > 14 years
- Diagnosis of inflammatory bowel disease (Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis, Microscopic Colitis) according to ECCO guidelines
Plus 2 more requirement(s). There are also 1 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 10000 participants are expected to take part.
- Start date: 2024-01-08.
- Main results expected around 2026-01-31 (estimate from the record).
- 1 study site listed (1 marked recruiting) in Italy.
Main thing being measured
- Percentage of patients with aggressive disease progression. (Baseline; through study completion, an average of 8 year)
In the researchers’ words
The study is observational with descriptive purposes, aimed at enhancing and deepening current knowledge and providing a foundation for future studies. Specifically, it seeks to identify predictive factors for aggressive disease progression, the development of frailty, the need for surgery and post-surgical outcomes, the development of neoplasia, the assessment of drug safety, and the quality of life in relation to…
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | IBD - Inflammatory Bowel Disease |
| Lead sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Enrollment | 10000 (estimated) |
| Start date | 2024-01-08 |
| Primary completion (est.) | 2026-01-31 |
| First posted | 2024-12-06 |
| Last updated | 2024-12-06 |
| Official title | The Multidisciplinary and Multiparametric Monitoring of Patients With Inflammatory Bowel Diseases: the Experience of the Reference Center of the Emilia-Romagna |
| ClinicalTrials.gov ID | NCT06721767 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * Signed informed consent * Age > 14 years * Diagnosis of inflammatory bowel disease (Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis, Microscopic Colitis) according to ECCO guidelines * Having undergone at least one outpatient visit and/or hospitalization at the Regional Reference Center for IBD "Massimo Campieri" * Acquisition of written informed consent from the patient and/or both parents/legal guardian Exclusion Criteria: \- None
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | Bologna | Italy | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.